DURECT Corp (DRRX) Misses Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts DRRX Hot Sheet
Price: $1.91 --0%
Financial Fact:
Collaborative research and development and other revenue: 352K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Collaborative research and development and other revenue: 352K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
DURECT Corp (NASDAQ: DRRX) reported Q2 EPS of ($0.12). Revenue for the quarter came in at $2.2 million.
For earnings history and earnings-related data on DURECT Corp (DRRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Lilly breaks ground on $6.5B Houston drug manufacturing site
- Brookfield prices $600M senior notes at 5.65% due 2031
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
